# Maze Therapeutics, Inc.: Form 8-K, filed Sep 2, 2025

- Company: [Maze Therapeutics, Inc.](/companies/maze.md) (CIK 1842295)
- Form: 8-K
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 07:00 ET
- Period: 2025-09-02
- Accession: 0001193125-25-193353
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842295/000119312525193353/d11864d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842295/000119312525193353/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842295/000119312525193353/d11864d8k.htm

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-193353. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.